NAKA
Nakamoto Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$7.23
+1.40%Year over year
Reported trailing growth
- Revenue
- +1657.8%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +62.0%
- EBITDA
- +91.5%
- EPS
- +93.8%
Three-year CAGR
- Revenue
- -21.7%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026